细胞·基因治疗工具

Cell and Gene Therapy Tools

出版日期: 2025年09月11日 | 出版商:

Strategic Directions International, Inc. | 英文 127 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

本研究报告《细胞与基因治疗工具》对全球细胞与基因治疗研发工具及产品市场进行了全面分析。报告考察了七大类工具的市场规模、成长动态和技术进步：通用技术、基因治疗工具、转染和递送、细胞富集、细胞生长培养基、生物反应器和低温保存。这些类别涵盖了从早期研究到符合 GMP 标准的临床开发的所有工作流程。

本研究强调了生物系统、基因编辑技术（例如 CRISPR）和先进的生物加工平台在塑造细胞和基因治疗未来方面将发挥的关键作用。市场洞察按产品类型、终端市场、行业、功能、地区和应用细分，并包含基于供应商市场占有率数据的竞争分析。报告特别关注併购的影响，以及经销商、经销商和第三方服务提供者在塑造市场动态方面的作用。

本报告基于广泛的一手和二手资料研究，为分析仪器行业的利益相关者提供切实可行的信息，重点关注促进细胞和基因疗法发展的技术。所有市场预测均以反映实际购买情况的最终用户价格为准。

The "Cell and Gene Therapy Tools & Products" report provides a comprehensive analysis of the global market for tools and products used in cell and gene therapy (C & GT) research and development. It examines market size, growth dynamics, and technological advancements across seven major categories of laboratory instrumentation and consumables: general techniques, gene therapy tools, transduction & transfection, cell enrichment, cell expansion media, bioreactors, and cryopreservation. These categories span the full workflow from early-stage research to GMP-compliant clinical development.

The study highlights the critical role of biological systems, gene editing technologies (e.g., CRISPR), and advanced bioprocessing platforms in shaping the future of C & GT. It offers segmented market insights by product type, end market, sector, function, region, and application, and includes competitive analysis with vendor market share data. Special attention is given to the impact of mergers and acquisitions, as well as the role of distributors, agents, and third-party service providers in shaping market dynamics.

Based on extensive primary and secondary research, this report delivers actionable intelligence for stakeholders in the analytical instrument industry, with a focus on technologies enabling the development of cell and gene therapies. All market estimates are presented at end-user prices, reflecting real-world purchasing conditions.